Study | Country Study period |
Population source | Exposure definition | Non-exposure definition | Sample size | Rmk |
---|---|---|---|---|---|---|
Colvin, 2010 |
Australia 2002 - 2005 |
All birth events in Western Australia (WA). | Ramipril dispensed from 14 days after the last menstrual period (LMP) to the end of first trimester or to the end of the pregnancy event. (This is a subgroup of exposure among the whole exposed group considered in the study). |
unexposed (general population or NOS)
All other births (those births to women dispensed a Pharmaceutical Benefits Scheme (PBS) medicine or not). |
22 / 106052 | Category D or X medicines also studied. Total nb of unexposed: 106052=106074-22. Birth defect: structural or functional abnormality. Most minor defects are not recorded in the BDR. Of all cases, about 90% have at least one major birth defect. |
Study | Country Study period |
Case | Control | Sample size | Rmk |
---|